Gender-related differences on P-glycoprotein-mediated drug intestinal transport in rats

Journal of Pharmacy and Pharmacology

Volumn 63, Issue 5, 2011, Pages 619-626

  Mariana, Ballent ^a,b   Adrián, Lifschitz ^a,b   Guillermo, Virkel ^a,b   Juan, Sallovitz ^a   Laura, Maté ^a,b   Carlos, Lanusse ^a,b  

^a UNIVERSIDAD NACIONAL DEL CENTRO DE LA PROVINCIA DE BUENOS AIRES   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

diffusion chambers; everted gut sacs; ivermectin; P glycoprotein; sex related differences

Indexed keywords

GLYCOPROTEIN P; IVERMECTIN; RHODAMINE 123; VALSPODAR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIFFUSION CHAMBER; DRUG ABSORPTION; DRUG TRANSPORT; DRUG UPTAKE; EX VIVO STUDY; FEMALE; ILEUM; INCUBATION TIME; INTESTINE ABSORPTION; INTESTINE SECRETION; JEJUNUM; MALE; NONHUMAN; RAT; SEX DIFFERENCE; WISTAR RAT;

ANIMALS; CYCLOSPORINS; FEMALE; ILEUM; INTESTINAL ABSORPTION; INTESTINES; IVERMECTIN; JEJUNUM; MALE; P-GLYCOPROTEIN; RATS; RATS, WISTAR; RHODAMINE 123; SEX FACTORS;

EID: 79954733406     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.2010.01230.x     Document Type: Article

References (40)

1. Gandhi M, et al,. Sex differences in pharmacokinetics and pharmacodynamics. Annu Rev Pharmacol Toxicol 2004; 44: 499-523. (Pubitemid 38263851)
2. Schuetz EG, et al,. Interindividual variation in expression of P-glycoprotein in normal human liver and secondary hepatic neoplasms. J Pharmacol Exp Ther 1995; 275: 1011-1018. (Pubitemid 26023635)
3. Salphati L, Benet LZ,. Modulation of P-glycoprotein expression by cytochrome P450 3A inducers in male and female rat livers. Biochem Pharmacol 1998; 55: 706-711.
4. Matheny C, et al,. Effect of prototypical inducing agents on P-glycoprotein and CYP3A expression in mouse tissues. Drug Metab Dispos 2001; 32: 1008-1014.
5. Cummins CL, et al,. Unmasking the dynamic interplay between intestinal P-glycoprotein and CYP3A4. J Pharmacol Exp Ther 2002; 300: 1036-1045. (Pubitemid 34165010)
6. Waxman DJ, et al,. Growth hormone regulation of male-specific rat liver P450s 2A2 and 3A2: induction by intermittent growth hormone pulses in male but not female rats rendered growth hormone deficient by neonatal monosodium glutamate. Mol Pharmacol 1995; 48: 790-797.
7. Anakk S, et al,. Insights into gender bias: rat cytochrome P450 3A9. J Pharmacol Exp Ther 2003; 305: 703-709. (Pubitemid 36459190)
8. Cummins CL, et al,. Sex-related differences in the clearance of cytochrome P450 3A4 substrates may be caused by P-glycoprotein. Clin Pharmacol Ther 2002; 72: 474-489. (Pubitemid 36237718)
9. Meibohm B, et al,. How important are gender differences in pharmacokinetics? Clin Pharmacokinet 2002; 41: 329-342. (Pubitemid 34713088)
10. Paine M, et al,. Do men and women differ in proximal small intestine CYP3A or P-glycoprotein expression? Drug Metab Dispos 2005; 33: 426-433. (Pubitemid 40279944)
11. McKellar QA, Benchaoui HA,. Avermectins and milbemycins. J Pharmacol Exp Ther 1996; 19: 331-351. (Pubitemid 26345990)
12. Gonzáles-Canga A, et al,. A review of the pharmacological interactions of ivermectin in several animal species. Curr Drug Metab 2009; 10: 359-368.
13. Pouliot JF, et al,. Reversal of P-glycoprotein-associated multidrug resistance by ivermectin. Biochem Pharmacol 1997; 53: 17-25.
14. Griffin J, et al,. Selamectin is a potent substrate and inhibitor of human and canine P-glycoprotein. J Vet Pharmacol Ther 2005; 28: 257-265. (Pubitemid 40896881)
15. Toutain PL, et al,. Comparative pharmacokinetics of doramectin and ivermectin in cattle. Vet Parasitol 1997; 72: 3-8. (Pubitemid 27501341)
16. Ndong TB, et al,. Ivermectin in Senegalese peulh sheep: influence of sex on plasma disposition. Vet Res Commun 2007; 31: 739-747. (Pubitemid 46951272)
17. Dupuy J, et al,. Pharmacokinetics of selamectin in dogs after topical application. Vet Res 2004; 28: 407-413. (Pubitemid 38992435)
18. Lifschitz A, et al,. Sex-related differences in the gastrointestinal disposition of ivermectin in the rat: P-glycoprotein involvement and itraconazole modulation. J Pharm Pharmacol 2006; 58: 1055-1062. (Pubitemid 44213637)
19. Barthe L, et al,. The improved everted gut sac: a simple method to study intestinal P-glycoprotein. Int J Pharm 1998; 173: 255-258.
20. American Veterinary Medical Association. Report of the AVMA Panel on Euthanasia. J Am Vet Med Assoc 2001; 218: 669-696.
21. Alvinerie M, et al,. Ivermectin in goat milk after subcutaneous injection. Vet Res 1993; 24: 417-421. (Pubitemid 23325860)
22. Lifschitz A, et al,. Comparative distribution of ivermectin and doramectin to parasite location tissues in cattle. Vet Parasitol 2000; 87: 327-338.
23. Carreño-Gõmez B, Duncan R,. Everted rat intestinal sacs: a new model for the quantification of glycoprotein mediated-efflux of anticancer agents. Anticancer Res 2000; 20: 3157-3162.
24. Ballent M, et al,. Modulation of the P-glycoprotein-mediated intestinal secretion of ivermectin: in vitro and in vivo assessments. Drug Metab Dispos 2006; 34: 457-463. (Pubitemid 43290904)
25. Muenster U, et al,. Characterization of substrates and inhibitors for the in vitro assessment of Bcrp mediated drug-drug interactions. Pharm Res 2008; 25: 2320-2326.
26. Jani M, et al,. Ivermectin interacts with human ABCG2. J Pharm Sci 2010; 100: 94-97.
27. Lenernnäs H,. Human jejunal effective permeability and its correlation with preclinical drug absorption models. J Pharm Pharmacol 1997; 49: 627-638.
28. Davis JL, et al,. Mucosal permeability of water-soluble drugs in the equine jejunum: a preliminary investigation. J Vet Pharmacol Ther 2006; 29: 379-385. (Pubitemid 44337692)
29. Schuetz EG, et al,. P-glycoprotein: a major determinant of rifampicin-inducible expression of cytochrome P4503A in mice and humans. Proc Natl Acad Sci U S A 1996; 93: 4001-4005. (Pubitemid 26144235)
30. Chiu S, et al,. Comparative in vivo and in vitro metabolism of ivermectin in steers, sheep, swine and rat. Drug Metab Rev 1987; 18: 289-302. (Pubitemid 18089657)
31. Alvinerie M, et al,. Ketoconazole increases the plasma levels of ivermectin in sheep. Vet Parasitol 2008; 157: 117-122.
32. Hugnet C, et al,. Multiple oral dosing of ketoconazole increases dog exposure to ivermectin. J Pharm Pharm Sci 2007; 10: 311-318. (Pubitemid 350055593)
33. Yumoto R, et al,. Pharmacokinetic interaction of cytochrome P450 3A-related compounds with rhodamine 123, a P-glycoprotein substrate, in rats pretreated with dexamethasone. Drug Metab Dispos 2001; 29: 145-151. (Pubitemid 32112928)
34. Potter JM, et al,. Area-under-the-curve monitoring of prednisolone for dose optimization in a stable renal transplant population. Ther Drug Monit 2004; 26: 408-414. (Pubitemid 38989660)
35. Merino G, et al,. Breast cancer resistance protein (BCRP/ABCG2) transports fluoroquinolone antibiotics and affects their oral availability, pharmacokinetic, and milk secretion. Drug Metab Dispos 2005; 34: 690-695.
36. MacLean C, et al,. Closing the gaps: a full scan of the intestinal expression of P-glycoprotein, breast cancer resistant protein and multidrug resistant-associated protein 2 in male and female rats. Drug Metab Dispos 2008; 36: 1249-1254. (Pubitemid 351929307)
37. Clark R,. Sex differences in antiretroviral therapy-associated intolerance and adverse events. Drug Saf 2005; 28: 1075-1083. (Pubitemid 41775999)
38. Floridia M, et al,. Gender differences in the treatment of HIV infection. Pharmacol Res 2008; 58: 173-182.
39. Nicolson TJ, et al,. Gender differences in drug toxicity. Trends Pharmacol Sci 2010; 31: 108-114.
40. Krecic-Shepard M, et al,. Faster clearance of sustained release verapamil in men versus women: continuing observations on sex-specific differences after oral administration of verapamil. Clin Pharmacol Ther 2000; 68: 286-292.